Recruiting
Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo)
NCT05663775
- Conditions
- Advanced Melanoma, Advanced Rectal Carcinoma, Diarrhea, +4 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada